DXCM:Dexcom Inc Snapshot | Charting | News | Options
$81.62 NASDAQ 7:34p ET
April 22 '25 		Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on DXCM
    No News Available
    Kuehn Law Encourages Investors of DexCom, Inc. to Contact Law Firm
    4:30p ET April 22 '25 PR Newswire
    Lifshitz Law PLLC Announces Investigations of Orthofix Medical Inc. (...
    5:11p ET February 4 '25 ACCESSWIRE
    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of...
    6:30p ET September 1 '24 ACCESSWIRE
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to ...
    6:16p ET September 1 '24 Newsfile Corp

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.